deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT05219838

Binding and Effects of Lu AG06466 in the Brain of Healthy Men

Interventional , Open-label, Positron Emission Tomography (PET) Study With [18F]-T-401 Investigating MAGL Enzyme Occupancy After Multiple Oral Doses of Lu AG06466

Sponsor: H. Lundbeck A/S

Conditions Healthy Participants
Interventions Lu AG06466
Updated 4 times since 2022 Last updated: Sep 8, 2022 Started: Jan 18, 2022 Primary completion: Aug 18, 2022 Completion: Aug 29, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Participants and is currently completed. H. Lundbeck A/S leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshotRecruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Sep 2022 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  4. Mar 2022 — Sep 2022 [monthly]

    Recruiting PHASE1

    First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • H. Lundbeck A/S
Data source: H. Lundbeck A/S

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations